Table 1.
Compound | Constriction no. (mean ± SEM)1 | Inhibition (%)2 | Relative activity3 |
---|---|---|---|
Vehicle control |
59.67 ± 6.8 |
- |
- |
Indomethacin |
13.50 ± 2.9 |
77.37 |
1*** |
7 |
44.33 ± 8.1 |
25.70 |
0.33 |
8 |
18.00 ± 3.7 |
69.83 |
0.90*** |
9 |
24.67 ± 5.5 |
58.65 |
0.76*** |
10 |
44.67 ± 2.8 |
25.14 |
0.32 |
11 |
23.83 ± 4.8 |
60.06 |
0.77*** |
12 |
24.33 ± 3.3 |
59.22 |
0.76*** |
13 |
17.67 ± 2.9 |
70.39 |
0.91*** |
14 |
ND4 |
- |
- |
15 | 15.50 ± 3.9 | 74.02 | 0.96*** |
1All compounds were administered i.p. at the dose of 50 μmol/kg, number of animals in each group n = 6.
2% of inhibition obtained by comparison with vehicle control group.
3Analgesic activity relative to Indomethacin,***P < 0.001 significant as compared to control.
4Not determined.